Top Story

Low testosterone may raise diabetes risk

May 1, 2016

In male mice, androgen receptor deficiency in beta cells impairs glucose-stimulated insulin secretion, increasing the risk for developing type 2 diabetes, according to recent study findings.

The study could help identify new treatments for type 2 diabetes in the large number of men with low testosterone due to age or prostate cancer therapies.

New studies evaluate Jardiance in patients with chronic heart failure

April 30, 2016
Two new outcome trials will investigate the SGLT2 inhibitor Jardiance for the treatment of people with chronic heart failure, Boehringer Ingelheim and Eli Lilly and…
In the Journals

Later onset, longer duration of Graves’ hyperthyroidism, smoking predictors for Graves’ orbitopathy

April 29, 2016
In patients with Graves’ hyperthyroidism, predictive factors for Graves’ orbitopathy include older age of disease onset, longer disease duration and smoking…
In the Journals

Urinary incontinence associated with type 1 diabetes in women

April 29, 2016
The odds of urinary incontinence increase with poor glycemic control in women with type 1 diabetes, according to recent study findings. Sara M. Lenherr, MD
In the Journals

Psoriasis associated with type 2 diabetes, obesity in twin study

April 29, 2016
Psoriasis had a strong association with type 2 diabetes and obesity in a nationwide study of Danish twins, indicating a common genetic etiology between psoriasis and…
More News Headlines »
CME Video

Navigating a New Era of Personalized Type 2 Diabetes Care: Taking the Road Less Traveled

This activity is supported by an independent educational grant from Boehringer-Ingelheim Pharmaceuticals, Inc. and Lilly USA, LLC.

In the United States, over 29 million people have diabetes, of which approximately 95% of cases are type 2 diabetes…
More »
Meeting News Coverage

VIDEO: Late diagnosis of Cushing's disease still a problem

April 8, 2016
More »
Highlights from ENDO 2016

Highlights from ENDO 2016


Obesity Consults® ObesityForum® 2015 Highlights

This activity is supported by an educational grant from Takeda Pharmaceuticals U.S.A., Inc. and Novo Nordisk, Inc.

Obesity has increased dramatically in the past 20 years and is considered a health care epidemic in the United States…
More »
Current Issues
View the Current Issues